We described that the relocation and accumulation of Tau protein in the nucleus in the early Alzheimer’s disease (AD) stages cause changes in the expression of disease-related genes, among these, the gene encoding the glutamate transporter VGluT1 and other genes involved in glutamate synaptic transmission. Here, MAPT is linked to Alzheimer disease.